Cefixime & Dicloxacillin ER Tablets – Zefral DX Tablets

Zefral DX Tablets: Cefixime & Dicloxacillin ER Tablets

Composition – Cefixime 200mg + Dicloxacillin 500mg

This formulation combines:
Cefixime, a third-generation cephalosporin, effective against gram-negative and some gram-positive bacteria by inhibiting cell wall synthesis.
Dicloxacillin, a penicillinase-resistant penicillin, specifically targets gram-positive bacteria, especially methicillin-sensitive Staphylococcus aureus (MSSA).Together, they deliver comprehensive coverage in conditions with uncertain or mixed bacterial etiologies.

KEY BENEFITS:
Broad & Targeted Coverage – Cefixime offers broad-spectrum coverage while Dicloxacillin targets gram-positive cocci including β-lactamase producing Staphylococcus aureus.
Enhanced Efficacy in Skin & Soft Tissue Infections – Ideal for managing mixed infections involving resistant gram-positive and gram-negative organisms.
Reduced Resistance Risk – Dual antibiotic synergy helps minimize bacterial resistance and recurrence in chronic infections.

Targeted Specalists:
Dermatologists
Diabetologists
ENT Specialists

 Disclaimer:
To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only